SMALL PHARMA
DEAD

Serial Number

90523956

Owner

Small Pharma LTD

Attorney

Thomas J. Romano

Filing Date

Feb 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SMALL PHARMA Trademark

Serial Number: 90523956

SMALL PHARMA is a trademark filed by Small Pharma LTD on February 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Small Pharma LTD

London EC2A4BX , GB

Entity Type: 99

CYBIN UK LTD

50 FEATHERSTONE STREET
LONDON EC1Y8RT , GB

Entity Type: 24

Trademark Details

Filing Date

February 10, 2021

Registration Date

Not Registered

Published for Opposition

June 7, 2022

Goods & Services

Pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; medical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; neuro-pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures

Advertising and marketing; business advisory services relating to the commercial exploitation of inventions; advisory services relating to business management and business operations; providing commercial and business contact information; assistance and advice regarding business organisation and management; business consulting services in the field of product development; wholesale and retail store services featuring pharmaceutical preparations, neuro-pharmaceutical preparations, medical, veterinary and sanitary preparations, apparatus and instruments and medical supplies; compilation of statistical data for use in scientific research for business purposes; compilation of statistical data relating to medical research for business purposes

Advisory services relating to intellectual property protection; intellectual property consultancy; intellectual property consultancy services in the field of patents and patent applications; legal consultancy relating to patent mapping; licensing of intellectual property; legal administration of licences; copyright management

Pharmaceutical advisory services; pharmaceutical consultation; pharmaceutical compounding services; pharmacy advisory services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; psychological support and mental health therapy services

Medical apparatus for use in treating respiratory diseases and conditions; medical devices for use in treating respiratory diseases and conditions; medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for medical use; inhalers for therapeutic use, sold empty; vaporizers for medical purposes; medical apparatus, namely, electric vaporizer for treatment of upper respiratory conditions; nebulizers for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory diseases and conditions; respiratory masks for medical purposes; medical fluid injectors; needle-based and needle-free injection systems; injection device for pharmaceuticals

Consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; testing of pharmaceuticals; scientific laboratory services; scientific advisory services; scientific and industrial research in the field of pharmaceuticals and healthcare; scientific investigations for medical purposes; scientific research services for medical purposes; advisory services relating to scientific research; scientific research in the field of pharmacy; scientific and technological research relating to patent mapping; Scientific and technological services, namely, compiling statistical data in the field of medical and scientific research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2025 EXRA
SOU EXTENSION 5 GRANTED
May 1, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 1, 2025 AITU
SOU EXTENSION 5 FILED
Jan 30, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 30, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 30, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 30, 2024 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 28, 2024 ASGN
ASSIGNED TO EXAMINER
Feb 26, 2024 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 31, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 31, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 31, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 31, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 31, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 9, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 9, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 9, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 7, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 30, 2022 ERRR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 14, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 14, 2022 XAEC
ASSIGNED TO LIE
Mar 14, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 18, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2021 NWOS
NEW APPLICATION ENTERED
Feb 15, 2021 NWAP